MedTrace Logo

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

NCT06980792 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2025-05-20

No results posted yet for this study

Summary

The study focuses on patients with synchronous liver metastasis from pancreatic adenocarcinoma that underwent both pancreatic and liver resection. The control group is made up of patients with resectable or borderline resectable pancreatic adenocarcinoma and synchronous liver metastasis that were excluded from surgery. Short and long-term outcomes will be compared to evaluate the safety and efficacy of simultaneous liver and pancreatic resection.

Conditions

  • Pancreas Neoplasms
  • Liver Metastasis
  • Pancreas Ductal Adenocarcinoma
  • Surgery of the Pancreatic Head
  • Liver Resection
  • Pancreatectomy

Interventions

PROCEDURE

Pancreatectomy and liver resection

Surgery for synchronous liver metastasis from PDAC with or without previous neoadjuvant chemotherapy

DRUG

Chemotherapy

Chemotherapy alone in potentially resectable patients with PDAC and synchronous liver metastasis

Sponsors & Collaborators

  • Azienda Ospedaliero-Universitaria di Modena

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06980792 on ClinicalTrials.gov